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Cell lines provide suitable experimental models for investiga-
tions of tumorigenesis, differentiation, reponse to treatment
and genetic regulation (Pattengale et al., 1981; Sundstrom &
Nilsson, 1978; Hayward et al., 1981; Nadlerr et al., 1981).
Most B cell lines are derived from Burkitt's lymphoma,
lymphoblastic lymphoma or large cell lymphoma (Dillman et
al., 1982; Epstein & Barr, 1964; Minowada et al., 1977). Cell
lines established from follicular lymphoma, multiple myeloma
and chronic lymphocytic leukaemia, although rare, have also
been reported (Minowada et al., 1977; Watanable et al.,
1980; Nilsson, 1977). However, the successful establishment
of immunoblastic lymphoma (IBL) cell lines has not been
reported (Mohamed & Alkatib, 1988). We recently estab-
lished a human lymphoma cell line, designated HOB1. To
our knowledge, HOBI is the first B-cell immunoblastic line.
HOBI was derived from an extranodal IBL in a 24-year-old
male patient. The primary tumour was in the jaw with exten-
sion to the gingiva and metastasis to the spinal cord. The
gingiva biopsy established the diagnosis of IBL by the Inter-
national Working Formulation (malignant lymphoma, IBL,
plasmacytoid type) (Figure la) (Hoppe, 1982). Surface
marker study revealed positivity for leukocyte common
antigen (Omary et al., 1980) and L26 (Reinherz et al., 1986),
indicating a case of B cell lymphoma (Figure lb). The patient
showed no response to the combinations of CHOP (cyclo-
phosphamide, adriamycin, vincristine and prednisone) and
MOPP (nitrogen mustard, vincristine, procarbazine and pred-
nisone) chemotherapy regimens, and died from central failure
3 months later. The cell line was established from one of the
gingival lesions by surgical excision. Active proliferation of
the cells was observed within 3-4 weeks of the culture, and
the first subculture was after 6 weeks. The cells, named
HOB1, were maintained continuously by serial cell transfers
for more than 48 months. The growth rate, morphology and
biological characteristics remained stable during the 4-year
culture period. HOBI cells grew in suspension and did not
adhere to the flask surface. The cell line reached a saturation
density of 1-2 x 106 cells ml-' with a doubling time of 22 h.
The HOBI cells were mostly round in shape. The cytoplasm
of the cells was basophilic with a few small vascuoles and the
nuclei were round with fine chromatin and one to three
nucleoli (Figure 2a). Ultrastructural examination showed
clear nuclei with fine dispersed chromatin and conspicious
nucleoli. The cytoplasmic organelles were sparse (Figure 2b).
Scanning electron microscopy revealed smooth surface mem-
brane with a few thin cytoplasmic processes (Figure 2c).
Immunocytohistological studies revealed that the cells were
positive for HLA-Dr (Baird, 1985), BI, Leu 14, B2 and B4
(Baird, 1985; Reinherz et al., 1986; Stashenko et al., 1980)
and OKT9 (Goding & Burns, 1981) (Figure 2d). They were
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Figure 1 The origin tumour showed the large plasmacytoid
immunoblastic neoplastic cell infiltrated in the deep dermis in-
cluding the papillary and upper reticular dermis of the gingiva
(a). Immunoperoxidase staining for L-26 revealed diffuse cyto-
plasmic membrane staining of the tumour cells (b).
negative for Igs and T cell markers, including Leu 1 (Engle-
man et al., 1981), CALLS (Ritz et al., 1980), Tdt (Janossy et
al., 1980), OKT 10 (Reinherz et al., 1980) and MT1 (Pop-
pema et al., 1981). These findings confirmed a B cell nature
for these cells, possibly originating from the activated B cell
(Figure 3). The HOBI cell line is confirmed to be derived
from malignant B cells by the comparison between HOBI
and the original tumour cells in terms of appearance and
immunological staining. The absence of the slg and cIg
indicates that the HOBI cell lines is characteristic of mature
B-cell nor pre-B cell neoplasms (Baird, 1985; Bhan et al.,
1981). It is difficult to differentiate between diffuse large and
immunoblastic B cell lymphoma on the basis of their surface
markers presentation because of their significant degree of
heterogenicity with B2, B4 and OKT9 markers (Freedman et
al., 1985; Borowitz et al., 1985). This cell line may facilitate
the study of IBL-associated antigen by its use as an
immunogen for the production of murine monoclonal
antibodies. Efforts to produce and characterise such
antibodies and the antigens they define are in progress in our
laboratory.
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Figure 2 Wright-Giemsa staining of HOBI cells after cytospin preparation. The cell is round or oval with fine chromatin and 1-3
nucleoli of the nuclei, and few vacuoles in the cytoplasm (x 216) (a). Electromicroscopy, the HOB1 cell has round nucleus with
dispersed chromatin and a conspicuous nucleolus. The cytoplasm is abundant with scanty of the mature micro-organelles (uranium
acetate and lead citrate, x 600) (b). Scanning electron microscopy of HOBI cells show smooth of surface membrane with scanty of
the cytoplasmic projections (x 2,400) (c). Immunoperoxidase staining of HOB1 cells by B1 reveal positive cytoplasmic membrane
staining and faint positive in golgi zone regions (x 216) (d).
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Figure 3 A schematic diagram of differentiation and transformation of normal B-lymphocytes (---) with their corresponding to
HOBI cell line ( ).
An analysis of more than 100 well-spread HOBI cells in
metaphase showed that the chromosome number ranged
from 22 to 73 with a hypodiploid modal number of 45. The
karyotype revealed multiple abnormalities including: t (2;4)
(;pl2-*cen-* qter::q26), t (3;4;18)(p25;q21;q21), del (2)
(pl2P25), t(8,14), +13, +20, +17, and +21 (Figure 4)
(Ming et al., 1987).
Total cellular DNAs from HOBI cells and Raji cells (used
as positive control) were digested with Eco-RI and analysed
for EBV DNA by Southern transfer. The results indicated
absence of EBV DNA in HOB I cell (data not shown).
Marked ascites was produced in the nude mice after 3-4
weeks of inoculation. Subsequently, each mouse was killed
and revealed milk-like ascites with numerous tumours in
omentum and also metastases to the lungs. The histology of
these tumours was similar to that of the original tumour.
The total RNAs extracted from HOBI cells and cells in
reactive hyperplastic lymphoid tissue (case as control) by the
single step method (Chomczynski & Sacchi, 1987) were
hybridised with 18 oncogene probes including c-myc, c-H-ras,
c-abl, c-fos, bas, erb-A, erb-B, v-fgr, mos, myb, L-myc, neu,
PFSV, N-ras, K-ras, rel, sis and src. Only two oncogenes,
c-myc and c-H-ras, were overexpressed in HOB 1 cells
(Figures 5 and 6). Other oncogenes were absent or undetec-
table. In addition, rearrangement of the c-myc gene but not
the c-H-ras gene was observed in HOBI cells (Figure 7).
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Figure 4 Karyotype of the HOBI cells (partial data).
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Figure 7 Hybridisation of 32P-labelled c-myc DNA to the Eco 1-
digested cellular DNAs from HOB1 cell line and normal hyper-
plastic lymphoid tissues (as a control). The fragments of Kpnl/
SstI-digested lambda at 11 DNA were used as size marker and
indicated in kb.
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Figure 5 Hybridisation of 32P-labelled c-myc or c-H-ras DNA to
40 fig total RNA from reactive hyperplastic lymphoid tissues (as
a control) and HOBI cell line. The ribosomal RNAs that served
as size markers are indicated (28S and 18S).
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Figure 6 Hybridisation of 32P-labelled DNA probe of actin,
c-H-ras, and c-myc to the indicated amounts of cellular total
RNA of HOBI and hyperplastic lymphoid tissues (as a control)
respectively.
Chromosomal study of Burkitt's lymphoma (BL) cell line
and tumours has revealed that translocation t (8:14)
(q24:q32) is seen in about 90% of cases (Manalova &
Manalova, 1972; Chaganti, 1983; Lenoir et al., 1982; Zech et
al., 1976; Bernheim et al., 1981), where as the translocation
t (14;18) (q32;q21) is the most common translocation in non-
Hodgkin's and non-Burkitt's lymphoma (Mitelman, 1980;
Yunis, 1983). The t (8;14) has been particularly well studied
in Burkitt's lymphoma cell lines. It has been shown to be
related to molecular rearrangement of the immunoglobin
genes and c-myc oncogenes (Berger & Bernheim, 1985; Taub
et al., 1982), and qualitative and quantitative abnormalities
in c-myc expression (Stanton et al., 1983; Mushinski et al.,
1983). This latter factor was considered to play a major role
in the malignant transformation of human B lymphocyte
(Hayward et al., 1981; Barbacid, 1986; Nishikori et al., 1984).
The HOBI cell line showed multiple chromosomal transloca-
tion, including those frequently observed in both EBV + and
EBV- lymphomas. Further experiments are needed to reach
a conclusion regarding a link between c-myc gene rearrange-
ment and t (8;14) or other chromosomal translocations in
HOB1 cells. From our data, the possible mechanism(s) of
malignant conversion of the HOB1 cell line include (a) c-myc
gene rearrangement and activation, and/ or (b) c-myc and
c-H-ras genes cooperating activation. In conclusion, HOB1 is
the first cell line derived from IBL with EBV- and multiple
chromosomal abnormalities. It may be a useful source of
cells for the study of molecular genetics in the oncogenesis of
IBL and the possible role of biological agents in growth
inhibition and differentiation.
This work is supported in part by the National Science Council
Research Grant of Republic of China NSC77-0412-B182-10, Chang-
Gung Memorial Hospital Research Fund no. CMRP244, and Ins-
titute of Biomedical Sciences, Academia Sinica, Republic of China.658 Y.-S. HO et al.
References
BAIRD, S. (1985). Antigenic markers on normal and malignant B
cells. In Monoclonal Antibodies in Cancer, Sell, S. & Reisfeld, R.
(eds) p. 147. Human Press: New Jersey.
BARBACID, M. (1986). Human oncogene. In Important Advances in
Oncology, Devita, V.T., Hellman, S. & Rosenberg, S.A. (eds)
p. 3. J.B. Lippincott: Philadelphia.
BERGER, R. & BERNHEIM, A. (1985). Cytogenetics of Burkitt's lym-
phoma-leukemia: a review. IARC Sci. Publ., 60, 65.
BERNHEIM, A., BERGER, R. & LENOIR, G. (1981). Cytogenetic
studies on African Burkitt's lymphoma cell lines: t (8;14), t (2;8)
and t (8;22) translocations. Cancer Genet. Cytogenet., 3, 307.
BHAN, A.K., NADLER, L.M., STASHENKO, P., MCCLUSKY, R.T. &
SCHLOSSMAN, S.F. (1981). Stages of B cell differentiation in
human lymphoid tissues. J. Exp. Med., 154, 737.
BOROWITZ, M.T., BOUSVAROS, A., BRYNES, R.K. & 5 others (1985).
Monoclonal antibody phenotyping of B cell non-Hodgkin's lym-
phomas. The Southeastern Cancer Study Group experience. Am.
J. Pathol., 121, 514.
CHAGANTI, R.S.K. (1983). Significance of chromosome change to
hematopoietic neoplasms. Blood, 62, 515.
CHOMCZYNSKI, P. & SACCHI, N. (1987). Single step method of
RNA isolated by acid quanidinium thiocyanate-phenol-
choroform extraction. Anal. Biochem., 162, 156.
DILLMAN, R.O., HANDLEY, H.H. & ROYSTON, I. (1982). Establish-
ment and characterization of Epstein-Barr-virus-negative lym-
phoma B-cell line from a patient with diffuse large cell lym-
phoma. Cancer Res., 42, 1368.
ENGLEMAN, E.G., WARNKE, R., FOX, R.I., DILLEY, J., BENIKE, C.F.
& LEVY, R. (1981). Studies of human T lymphocyte antigen
recognized by a monoclonal antibody. Proc. Natl Acad. Sci.
USA, 78, 1791.
EPSTEIN, M.A. & BARR, Y.M. (1964). Cultivation in vitro of human
lymphoblasts Burkitt's malignant lymphoma. Lancet, i, 525.
FREEDMAN, A.S., BOYD, A.W., ANDERSON, K.C. & 4 others (1985).
Immunologic heterogeneity of diffuse large cell lymphoma. Blood,
65, 630.
GODING, J.W. & BURNS, G.F. (1981). Monoclonal antibody OKT 9
recognizes the receptor for transferrin on human acute lym-
phocytic leukemia cells. J. Immunol., 127, 1256.
HAYWARD, W.S., NEEL, B.G. & ASTRIN, S.M. (1981). Activation of a
cellular oncogene by a promoter inservation in ALV-induced
lymphoid leukosis. Nature, 298, 679.
HOPPE, R.T. (1982). A working formulation of non-Hodgkin's lym-
phomas for clinical usage: clinicopathological and prognostic cor-
relations. In Malignant Lymphomas, Rosenberg, S.A. & Kaplan,
H.S. (eds) p. 469. Academic Press: New York.
JANOSSY, G., BOLLUMS, F.J., BRADSTOCK, K.F. & ASHLEY, J.
(1980). Cellular phenotypes of normal and leukemic
hematopoietic cells determined by selected antibody combination.
Blood, 56, 430.
LENOIR, G.M., PREUD'HOMNE, J.L., BERNHEIM, A. & BERGER, R.
(1982). Correlation between immunoglobulin light chain expres-
sion and variant translocation in Burkitt's lymphoma. Nature,
298, 474.
MANALOV, G. & MANALOVA, Y. (1972). Marker band in one
chromosome 14 from Burkitt's lymphoma. Nature, 237, 33.
MING, P.L., TZENG, C.C. & HO, Y.S. (1987). Cytogenetic and
immunologic characterization of a cell line from an extranodal
immunoblast lymphoma. Am. J. Human Genet., 41, A33.
MINOWADA, J., TSUBOTA, T. & NAKAZAWA, S. (1977). Establish-
ment and characterization of leukemic T cell lines, B cell lines,
and null cell line: a progress report on surface antigen study of
fresh lymphatic leukemia in man. In Haematology and Blood
Transfusion, Vol. 20, Thierfelder, S. (ed.) p. 241. Springer-Verlag:
Berlin, Heidelberg, New York.
MITELMAN, F. (1980). Marker chromosome 14+ in human cancer
and leukemia. Adv. Cancer Res., 34, 141.
MOHAMED, A.N. & AL-KATIB, A. (1988). Establishment and charac-
terization of a human lymphoma cell line (WSH-NHL) with 14;
18 translocation. Leukemia Res., 12, 833.
MUSHINSKI, J.F., BANKER, S.R., POTTER, M. & REDDY, E.P. (1983).
Increased expression of myc-related oncogene mRNA charac-
terizes most BALB/c plasmocytomas induced by pristane or
Abelson murine leukemia virus. Proc. Natl Acad. Sci. USA, 80,
1073.
NADLERR, L.M., STASHENKO, P., RITZ, J., HARDY, R., PESANDO,
J.M. & SCHLOSSMAN, S.F. (1981). A unique cell surface antigen
identifying lymphoid malignancies of B cell origin. J. Clin.
Invest., 67, 134.
NILSSON, K. (1977). Establishment cell lines as tolls in the study of
human lymphoma and myeloma cell characteristics. In
Haematology and Blood Transfusion, Vol. 20, Thierfelder, S. (ed.)
p. 253. Springer Verlag: Berlin, Heidelberg, New York.
NISHIKORI, M., HANSEN, H., JHANWAN, S. & 5 others (1984).
Establishment of a neartertraploid B-cell lymphoma line with
duplication of the 8;14 translocation. Cancer Genet. Cytogenet.,
12, 39.
OMARY, M.B., TROWBRIDGE, I.S. & BATTIFORA, H.A. (1980).
Human homologue of murine T200 glycoprotein. J. Exp. Med.,
152, 842.
PATTENGALE, P.K., GIDLUND, M., NILSSON, K., SUNDSTROMA, C.,
ORN, A. & WIGZELL, H. (1981). Lysis of human B-lymphocyte-
derived lymphoma/leukemia cells of established cell lines by
interferon-activated natural killer (NK) cells. Int. J. Cancer, 28,
459.
POPPEMA, S., BHAM, A.K., REINHERZ, E.L., MCCLUSKEY, R.T. &
SCHLOSSMAN, S.F. (1981). Distribution of T cell subsets in
human lymph nodes. J. Exp. Med., 153, 130.
REINHERZ, E.L., HAYNES, B.F., NADLER, L.M. & BERSTEIN, I.D.
(1986). Leukocyte Typing II. Springer-Verlag: New York.
REINHERZ, E.L., KUNG, P.C., GOLDSTEIN, G., LEVEY, R.H. &
SCHLOSSMAN, S.F. (1980). Discrete stages of human intrathymic
differentiation: analysis of normal thymocytes and leukemic lym-
phoblasts of T-cell lineage. Proc. Natl Acad. Sci. USA, 77, 1588.
RITZ, J., PESANDO, J.M., NOTIS-McCONARTY, J., LAZARUS, H. &
SCHLOSSMAN, S.F. (1980). A monoclonal antibody to human
acute lymphoblastic leukemia antigen. Nature, 282, 583.
STANTON, L.W., WATT, R. & MARCU, K.B. (1983). Translocation,
Breakage, and truncated transcripts of c-myc oncogene in murine
plasmacytomas. Nature, 303, 401.
STASHENKO, P., NADLER, L.M., HARDY, R. & SCHLOSSMAN, S.F.
(1980). Characterization of a human B lymphocyte-specific
antigen. J. Immunol., 125, 1678.
SUNDSTROM, C. & NILSSON, K. (1978). Human malignant lym-
phomas in vitro. Characterization of biopsy cells on establishment
of permanent cell lines. Acta Pathol. Microbiol. Scand., 86, 173.
TAUB, R., KIRSCH, I., MORTON, C. & 5 others (1982). Translocation
of the c-myc gene into the immunoglobulin heavy chain locus in
human Burkitt lymphoma and murine plasmcytoma cell. Proc.
Natl Acad. Sci. USA, 79, 7873.
WATANABE, S., KUROKI, M., SATO, Y., SHIMOSATO, Y. &
HASEGAWA, T. (1980). The establishment of a cell line (NH-AR)
from a human nodular lymphoma and a comparison with lym-
phoblastoid cell line. Cancer, 46, 2438.
YUNIS, J.J. (1983). The chromosomal basis of human neoplasia.
Science, 221, 277.
ZECH, L., HAGLUND, V., NILSSON, N. & KLEIN, G. (1976). Charac-
teristic chromosome abnormalities in biopsies and lymphoid cell
lines from patients with Burkitt's and non-Burkitt's lymphoma.
Int. J. Cancer, 17, 47.